According to filings with the U.S. Securities and Exchange Commission, Colossal Biosciences is raising $150,000,000.00 in new funding. Sources indicate as part of senior management Senior Executive, Brian Beard played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Colossal Biosciences
The science of genetics. The business of discovery. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.

To learn more about Colossal Biosciences, visit http://colossal.com/

Contact:
Brian Beard, Senior Executive
512-576-0777

SOURCE: http://www.intelligence360.io/
Copyright (c) 2023 SI360 Inc. All rights reserved.